The meta-analysis of Jin et al. included only 10 studies for evaluating the association between MTHFR C677T polymorphism and HCC risk and may have insufficient statistical power to detect a true effect or may have generated a fluctuated risk estimate. The gene discussed is MTHFR; the disease is hepatocellular carcinoma.